Avalo Therapeutics, Inc.
AVTX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001534120
In the last 90 days, Avalo Therapeutics, Inc. insiders filed 0 open-market purchases and 9 sales; 126 institutions reported holding it in 13F filings for Q2 2026, worth $1.31B in total; no superinvestor holds it.
13F holders, Q1 2025
Institutional positions in Avalo Therapeutics, Inc. as of Mar 31, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 34
- +1 vs. Q4 2024
- Shares held
- 8.26M
- +724.5K (+9.6%) vs. Q4 2024
- Total value
- $66.1M
- +$10.2M (+18.2%) vs. Q4 2024
- New holders
- 5
- 11 more added
- Sold out
- 4
- 4 more reduced
Compare with Q4 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting AVTX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 126 | $1.31B |
| Q1 2026 | 97 | $469.6M |
| Q4 2025 | 84 | $361.1M |
| Q3 2025 | 66 | $194.7M |
| Q2 2025 | 36 | $39.1M |
| Q1 2025 | 34 | $66.1M |
| Q4 2024 | 33 | $56.0M |
| Q3 2024 | 29 | $63.2M |
| Q2 2024 | 21 | $9.62M |
| Q1 2024 | 18 | $1.90M |
| Q4 2023 | 12 | $209.4K |
| Q3 2023 | 28 | $158.9K |
| Q2 2023 | 26 | $862.7K |
| Q1 2023 | 32 | $16.0M |
| Q4 2022 | 28 | $28.0M |
| Q3 2022 | 27 | $18.4M |
| Q2 2022 | 54 | $34.7M |
| Q1 2022 | 71 | $56.2M |
| Q4 2021 | 75 | $136.0M |
| Q3 2021 | 77 | $175.5M |
| Q2 2021 | 71 | $218.1M |
| Q1 2021 | 70 | $180.4M |
Institutions, Q1 2025
Shares, value and share of portfolio for each institution holding Avalo Therapeutics, Inc.; share changes are against Q4 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Avion Wealth | 5 | $0 | 0.00% | +5 | New |
| Parallel Advisors, LLC | 1 | $8 | 0.00% | 00.0% | Unchanged |
| Key Financial Inc | 1 | $8 | 0.00% | 00.0% | Unchanged |
| Activest Wealth Management | 1 | $8 | 0.00% | 00.0% | Unchanged |
| Group One Trading, L.P. | 2 | $16 | 0.00% | 00.0% | Unchanged |
| Advisor Group Holdings, Inc. | 2 | $16 | 0.00% | 00.0% | Unchanged |
| BNP Paribas Arbitrage, SA | 4 | $32 | 0.00% | 00.0% | Unchanged |
| SBI Securities Co., Ltd. | 22 | $176 | 0.00% | 00.0% | Unchanged |
| Royal Bank of Canada | 212 | $2.00K | 0.00% | −117,144−99.8% | Reduced |
| Morgan Stanley | 360 | $2.88K | 0.00% | +350+3,500.0% | Added |
| JPMorgan Chase & Co | 1,105 | $8.85K | 0.00% | +1,103+55,150.0% | Added |
| Bank of America Corp | 5,673 | $45.4K | 0.00% | +3+0.1% | Added |
| ADAR1 Capital Management, LLC | 10,000 | $80.1K | 0.02% | +10,000 | New |
| HRT Financial LP | 10,289 | $82.0K | 0.00% | −29,711−74.3% | Reduced |
| Walleye Capital LLC | 20,223 | $162.0K | 0.00% | +746+3.8% | Added |
| Northern Trust Corp | 22,673 | $181.6K | 0.00% | 00.0% | Unchanged |
| Sio Capital Management, LLC | 71,458 | $572.4K | 0.17% | 00.0% | Unchanged |
| UBS Group AG | 98,951 | $792.6K | 0.00% | +432+0.4% | Added |
| Allostery Investments LP | 107,141 | $858.2K | 1.24% | +33,827+46.1% | Added |
| Geode Capital Management, LLC | 107,812 | $864.4K | 0.00% | +2,959+2.8% | Added |
| Velan Capital Investment Management LP | 111,972 | $896.9K | 0.92% | +2,000+1.8% | Added |
| BlackRock, Inc. | 133,726 | $1.07M | 0.00% | +491+0.4% | Added |
| Vanguard Group Inc | 166,941 | $1.34M | 0.00% | +1,140+0.7% | Added |
| Ikarian Capital, LLC | 200,000 | $1.60M | 0.52% | −770,259−79.4% | Reduced |
| Adviser Investments LLC | 312,779 | $2.51M | 0.03% | +312,779 | New |
| Commodore Capital LP | 483,000 | $3.87M | 0.29% | 00.0% | Unchanged |
| TCG Crossover Management, LLC | 483,000 | $3.87M | 0.53% | 00.0% | Unchanged |
| Perceptive Advisors LLC | 520,000 | $4.17M | 0.15% | +520,000 | New |
| Affinity Asset Advisors, LLC | 657,154 | $5.26M | 0.82% | +106,389+19.3% | Added |
| Deep Track Capital, LP | 859,876 | $6.89M | 0.22% | −7,124−0.8% | Reduced |
| Nantahala Capital Management, LLC | 900,000 | $7.21M | 0.60% | +900,000 | New |
| OrbiMed Advisors LLC | 967,000 | $7.75M | 0.19% | 00.0% | Unchanged |
| Ra Capital Management, L.P. | 967,000 | $7.75M | 0.13% | 00.0% | Unchanged |
| BVF Inc | 1,036,679 | $8.30M | 0.34% | 00.0% | Unchanged |
| Boothbay Fund Management, LLC | 0 | $0 | 0.00% | −163,992−100.0% | Sold out |
| Bank of Montreal | 0 | $0 | 0.00% | −60,000−100.0% | Sold out |
| Marshall Wace, LLP | 0 | $0 | 0.00% | −15,323−100.0% | Sold out |
| Tower Research Capital LLC (TRC) | 0 | $0 | 0.00% | −4,130−100.0% | Sold out |